![Sireesh Appajosyula](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sireesh Appajosyula
Directeur/Membre du Conseil chez
HEPION PHARMACEUTICALS, INC.
Fortune : 273 364 $ au 31/07/2026
Profil
Sireesh Appajosyula currently works at Hepion Pharmaceuticals, Inc., as Director from 2026, Highpoint Pharmaceuticals LLC, as Managing Member from 2018, and Channel Bioconsulting LLC, as Managing Partner from 2015.
Dr. Appajosyula also formerly worked at Canton Strategic Holdings, Inc., as Chief Financial Officer in 2025, 9 Meters Biopharma, Inc., as SVP-Corporate Development & Operations, and Salix Pharmaceuticals, Inc., as Head-Business Development.
Dr. Appajosyula received his undergraduate degree from Rutgers State University of New Jersey and doctorate degree from Ernest Mario School of Pharmacy.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/08/2026 | 3 250 000 ( 3,6 % ) | 149 500 $ | 31/07/2026 | |
| 16/06/2026 | 64 178 ( 0,08 % ) | 123 864 $ | 31/07/2026 |
Postes actifs de Sireesh Appajosyula
| Sociétés | Poste | Début |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 16/03/2026 |
Highpoint Pharmaceuticals LLC | Corporate Officer/Principal | 01/01/2018 |
Channel Bioconsulting LLC | Corporate Officer/Principal | 01/01/2015 |
Anciens postes connus de Sireesh Appajosyula
| Sociétés | Poste | Fin |
|---|---|---|
| CANTON STRATEGIC HOLDINGS, INC. | Directeur Général | - |
| 9 METERS BIOPHARMA, INC. | Directeur des opérations | 17/07/2023 |
Salix Pharmaceuticals, Inc.
 Salix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Formation de Sireesh Appajosyula
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
24
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Hepion Pharmaceuticals, Inc.
 Hepion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapy for treatment of chronic liver diseases | Health Technology |
Salix Pharmaceuticals, Inc.
Salix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernest Mario School of Pharmacy
 Ernest Mario School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
9 Meters Biopharma, Inc.
 9 Meters Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for people with rare digestive diseases and gastrointestinal conditions | Health Technology |
Tharimmune, Inc.
 Tharimmune, Inc. Data Processing ServicesTechnology Services Engages in institutional blockchain infrastructure and digital asset treasury management and clinical stage bio-technology services | Technology Services |
Highpoint Pharmaceuticals LLC | |
Channel Bioconsulting LLC |
